業績

2009年度 :: 著書・雑誌 :: 英文 :: 原著 :: 業績

Guidelines for the management of Helicobacter pylori infection in Japan:2009 revised edition.

Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, Ota H, Uemura N, Murakami K, Satoh K, Sugano K, ; Japanese Society for Helicobacter Research.

Helicobacter. 15: 1-20. 2010. 2.

The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma.

Chuma M, Hige S, Kamiyama T, Meguro T, Nagasaka A, Nakanishi K, Yamamoto Y, Nakanishi M, Kohara T, Sho T, Yamamoto K, Horimoto H, Kobayashi T, Yokoo H, Matsushita M, Todo S, Asaka M.

J Gastroenterol. 44: 991-999. 2009. 9.

Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B.

Karino Y, Toyota J, Kumada, Katano Y, Izumi N, Kobashi H, Sata M, Moriyama M, Imazeki F, Kage M, Masaki N, Seriu T, Omata M.

Hepatol Int. 4: 414-422. 2010. 2.

Peroral cholangioscopy for the diagnosis of bile duct carcinoma with extensive intraepithelial spread.

Kawakami H, Kuwatani M, Etoh K, Haba S, Yamato H, Shinada K, Kondo S, Kubota K, Matsuno Y, Asaka M.

Endoscopy. 41: 959-964. 2009. 11.

A prospective randomized controlled multicenter trial of duodenoscopes with 5° and 15° backward-oblique angle using wire-guided cannulation: effects on selective cannulation of the common bile duct in endoscopic retrograde cholangiopancreatography.

Kawakami H, Maguchi H, Hayashi T, Yanagawa N, Chiba A, Hisai H, Amizuka H.

J Gastroenterol. 44: 1140-1146. 2009. 11.

Successful voriconazole treatment of invasive pulmonary aspergillosis in a patient with acute biphenotypic leukemia.

Kobayashi K, Ogasawara M, Kiyama Y, Miyazono T, Kagawa K, Imai K, Hirano T, Kobayashi N, Tanimoto M, Kasai M.

Acta Medica Okayama. 63: 213-216. 2009. 8.

Diffuse large B-cell lymphoma with massive portal vein tumor thrombosis in a patient with alcoholic cirrhosis: A case report and literature review.

Natsuizaka M, Kudo M, Suzuki M, Takano M, Tsuyuguchi M, Kawamura N, Noguchi S, Wada A, Nakata M, Ogasawara M, Kiyama Y, Asaka M, Kasai M.

Intern Med. 48: 805-808. 2009. 5.

Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene.

Nishida T, Takahashi T, Nishitani A, Doi T, Shirao K, Komatsu Y, Nakajima K, Hirota S.

Int J Clin Oncol. 14: 143-149. 2009. 4.

Involvement of tazarotene-induced gene 1 (TIG1) in proliferation and differentiation of human adipose tissue-derived mesenchymal stem cells.

Ohnishi S, Okabe K, Obata H, Otani K, Ishikane S, Ogino H, Kitamura S, Nagaya N.

Cell Proliferation. 133: 309-316. 2009. 6.

Effects of preoperative administration of omeprazole on bleeding after endoscopic submucosal dissection: a prospective randomized controlled trial.

Ono S, Kato M, Ono Y, Nakagawa M, Nakagawa S, Shimizu Y, Asaka M.

Endoscopy. 41: 299-303. 2009. 4.

Immediate acid-suppressing effects of ranitidine hydrochloride and rabeprazole sodium following initial administration and reintroduction: A randomized, cross-over study using wireless pH monitoring capsules.

Ono S, Kato M, Ono Y, Imai A, Yoshida T, Shimizu Y, Asaka M.

J Gastroenterol Hepatol. 24: 639-645. 2009. 4.

Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study.

Ono S, Kato M, Imai A, Yoshida T, Hirota J, Hata T, Takagi K, Kamada G, Ono Y, Nakagawa M, Nakagawa S, Shimizu Y, Takeda H, Asaka M.

J Clin Biochem Nutr. 45: 248-253. 2009. 8.

Fascin is involved in tumor necrosis factor-alpha-dependent production of MMP9 in cholangiocarcinoma.

Onodera M, Zen Y, Harada K, Sato Y, Ikeda K, Sato H, Ohta T, Asaka M, Nakanuma Y.

Lab Invest. 89: 1261-1274. 2009. 11.

Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.

Onozawa M, Hashino S, Haseyama Y, Hirayama Y, Iizuka S, Ishida T, Kaneda M, Kobayashi H, Kobayashi R, Koda K, Kurosawa M, Masauji N, Matsunaga T, Mori A, Mukai M, Nishio M, Noto S, Ota S, Sakai H, Suzuki N, Takahashi T, Tanaka J, Torimoto Y, Yoshida M, Fukuhara T.

Biol Blood Marrow Transplant. 15: 724-729. 2009. 6.

Short-term and long-term outcome of endoluminal gastroplication for the treatment of GERD: the first multicenter trial in Japan.

Ozawa S, Kumai K, Higuchi K, Arakawa T, Kato M, Asaka M, Katada N, Kuwano H, Kitajima M.

J Gastroenterol. 44: 675-684. 2009. 7.

Endoscopic ultrasonographic evaluation of hemodyna-mics related to variceal relapse in esophageal variceal patients.

Sato T, Yamazaki K, Akaike J, Toyota J, Karino Y, Ohmura T.

Hepatology Research. 39: 126-133. 2009. 4.

Evaluation of therapeutic effects on rectal varices using percutaneous color Doppler ultrasonography.

Sato T, Yamazaki K, Akaike J, Toyota J, Karino Y, Ohmura T.

Hepatol Res. 39: 694-699. 2009. 7.

Diagnosis of gastric varices and evaluation of the effectiveness of treatment using transabdominal color Doppler ultrasonography.

Sato T, Yamazaki K, Akaike J.

J Ultrasound Med. 28: 1125-1131. 2009. 9.

Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.

Shigematsu A, Yasumoto A, Yamamoto S, Sugita J, Kondo T, Onozawa M, Kahata K, Endo T, Ota S, Sato N, Takahata M, Okada K, Tanaka J, Hashino S, Nishio M, Koike T, Asaka M, Imamura M.

Biol Blood Marrow Transplant. 15: 679-685. 2009. 6.

Long-term outcome after endoscopic resection in patients with hypopharyngeal carcinoma invading the subepithelium:a case series.

Shimizu Y, Yoshida T, Kato M, Ono S, Nakagawa M, Homma A, Oridate N, Asaka M.

Endoscopy. 41: 374-376. 2009. 4.

Low-grade dysplasia component in early invasive squamous cell carcinoma of the esophagus.

Shimizu Y, Yoshida T, Kato M, Hirota J, Ono S, Nakagawa M, Kobayashi T, Kubota K, Asaka M.

J Gastroenterol Hepatol. 25: 314-318. 2010. 2.

Rikkunshito ameliorates the aging-associated decrease in ghrelin receptor reactivity via phosphodiesterase III inhibition.

Takeda H, Muto S, Hattori T, Sadakane C, Tsuchiya K, Katsurada T, Ohkawara T, Oridate N, Asaka M.

Endocrinology. 151: 244-252. 2010. 1.

Increased number of CD16+CD56dim NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation.

Tanaka J, Sugita J, Asanuma S, Arita K, Shono Y, Kikutchi M, Shiratori S, Wakasa K, Yasumoto A, Shigematu A, Kondo T, Kobayashi T, Asaka M, Imamura M.

Human Immunol . 70: 701-705. 2009. 9.

Serum macrophage migration inhibitory factor (MIF) levels after allogeneic hematopoietic stem cell transplantation.

Toubai T, Shono Y, Nishihira J, Ibata M, Sugita J, Kato N, Ohkawara T, Tone S, Lowler KP, Ota S, Tanaka J, Asaka M, Reddy P, Imamura M.

Int J Lab Hemato. 31: 161-168. 2009. 4.

Serum soluble tumor necrosis factor-related apoptosis-inducing ligand level after allogeneic hematopoietic stem cell transplantation.

Toubai T, Shono Y, Tone S, Ibata M, Kato N, Malter C, Lowler KP, Ota S, Tanaka J, Asaka M, Imamura M.

Leuk Lymphoma. 50: 844-847. 2009. 5.

Analysis of reactivation of hepatitis B virus in the treatment of B cell non-Hodgkin’s lymphoma in Hokkaido.

Tsutsumi Y, Shigematsu A, Hashino S, Tanaka J, Chiba K, Masauzi N, Kobayashi H, Kurosawa M, Iwasaki H, Morioka M, Asaka M, Imamura M.

Ann Hematol. 88: 375-377. 2009. 4.

Changes in hepatitis C virus antibody titer and viral RNA load in non-Hodgkins lymphoma patients after rituximab chemotherapy.

Tsutsumi Y, Ichiki K, Shiratori S, Kawamura T, Tanaka J, Asaka M, Imamura M, Masauzi N.

Int J Lab Hemato. 31: 468-470. 2009. 8.

Modified-irinotecan/fluorouracil/levoleucovorin therapy as ambulatory treatment for metastatic colorectal cancer: results of phase I and II studies.

Yuuki S, Komatsu Y, Fuse N, Kato T, Miyagishima T, Kudo M, Watanabe M, Tateyama M, Kunieda Y, Wakahama O, Sakata Y, Asaka M.

Clin Drug Investig. 30: 243-249. 2010. 2.

>